Table 3 Fold increase of cytokine expression in patients with neovascular AMD and geographic atrophy (GA) as compared controls for different stimulation conditions.

0.99 (0.56–1.76)

0.98

1.28 (0.58–2.80)

0.54

1.29 (0.72–2.32)

0.39

1.91 (0.90–4.04)

0.093

0.64 (0.32–1.28)

0.21

1.03 (0.42–2.56)

0.95

1.30 (0.71–2.39)

0.40

1.24 (0.57–2.72)

0.59

1.13 (0.63–2.01)

0.68

1.76 (0.75–4.13)

0.20

0.93 (0.53–1.65)

0.81

0.74 (0.35–1.53)

0.41

0.81 (0.42–1.54)

0.52

0.46 (0.20–1.06)

0.068

0.60 (0.30–1.20)

0.15

0.77 (0.35–1.70)

0.52

0.63 (0.34–1.17)

0.14

0.71 (0.32–1.55)

0.39

1.41 (0.63–3.14)

0.40

2.61 (1.00–6.83)

0.051

0.82 (0.45–1.48)

0.51

0.97 (0.49–1.93)

0.93

1.31 (0.73–2.35)

0.37

1.03 (0.49–2.19)

0.94